These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


131 related items for PubMed ID: 7590366

  • 1. Hypertension: special concerns in managing the older patient.
    Gold G, Fishman P.
    Geriatrics; 1995 Nov; 50(11):39-45 quiz 46-7. PubMed ID: 7590366
    [Abstract] [Full Text] [Related]

  • 2. The future of antihypertensive treatment.
    Israili ZH, Hernández-Hernández R, Valasco M.
    Am J Ther; 2007 Nov; 14(2):121-34. PubMed ID: 17414579
    [Abstract] [Full Text] [Related]

  • 3. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P, Vasconcelos N, Santos I, Almeida L, Nazaré J, Carmona J.
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [Abstract] [Full Text] [Related]

  • 4. ESH-ESC guidelines for the management of hypertension.
    Erdine S, Ari O, Zanchetti A, Cifkova R, Fagard R, Kjeldsen S, Mancia G, Poulter N, Rahn KH, Rodicio JL, Ruilope LM, Staessen J, van Zwieten P, Waeber B, Williams B.
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [Abstract] [Full Text] [Related]

  • 5. [Hypertension as a function of age].
    Gensini GF, Corradi F.
    Ital Heart J; 2000 Jun; 1 Suppl 2():23-31. PubMed ID: 10905125
    [Abstract] [Full Text] [Related]

  • 6. [Hypertension in the aged: when to treat it?].
    Steiner A, Vetter W.
    Schweiz Rundsch Med Prax; 1991 Jun 18; 80(25):692-5. PubMed ID: 1857900
    [Abstract] [Full Text] [Related]

  • 7. Management of hypertension and cerebrovascular disease in the elderly.
    Pedelty L, Gorelick PB.
    Am J Med; 2008 Aug 18; 121(8 Suppl):S23-31. PubMed ID: 18638616
    [Abstract] [Full Text] [Related]

  • 8. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S, Bakir SE.
    Drugs; 2000 Aug 18; 59 Spec No 2():25-37. PubMed ID: 11002856
    [Abstract] [Full Text] [Related]

  • 9. The Hypertension Optimal Treatment study and the importance of lowering blood pressure.
    Hansson L.
    J Hypertens Suppl; 1999 Feb 18; 17(1):S9-13. PubMed ID: 10340838
    [Abstract] [Full Text] [Related]

  • 10. [Heart, brain and hypertension].
    Lüscher TF, Sturzenegger M, Noll G.
    Schweiz Med Wochenschr; 1996 Aug 24; 126(34):1449-56. PubMed ID: 8848709
    [Abstract] [Full Text] [Related]

  • 11. Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a hypertensive population at high cardiovascular risk.
    Weber MA, Bakris GL, Dahlöf B, Pitt B, Velazquez E, Gupte J, Lefkowitz M, Hester A, Shi V, Weir M, Kjeldsen S, Massie B, Nesbitt S, Ofili E, Jamerson K.
    Blood Press; 2007 Aug 24; 16(1):13-9. PubMed ID: 17453747
    [Abstract] [Full Text] [Related]

  • 12. Hypertension and the older diabetic.
    Aronow WS.
    Clin Geriatr Med; 2008 Aug 24; 24(3):489-501, vi-vii. PubMed ID: 18672184
    [Abstract] [Full Text] [Related]

  • 13. Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease.
    He J, Whelton PK.
    J Hypertens Suppl; 1999 Jun 24; 17(2):S7-13. PubMed ID: 10465061
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May 24; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 16. Lifestyle modifications to prevent and control hypertension. 1. Methods and an overview of the Canadian recommendations. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Campbell NR, Burgess E, Choi BC, Taylor G, Wilson E, Cléroux J, Fodor JG, Leiter LA, Spence D.
    CMAJ; 1999 May 04; 160(9 Suppl):S1-6. PubMed ID: 10333847
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hypertension: how does management change with aging?
    Little MO.
    Med Clin North Am; 2011 May 04; 95(3):525-37, x. PubMed ID: 21549876
    [Abstract] [Full Text] [Related]

  • 19. Blood pressure levels, risk factors and antihypertensive treatments: lessons from the SHEAF study.
    Mallion JM, Genès N, Vaur L, Clerson P, Vaïsse B, Bobrie G, Chatellier G.
    J Hum Hypertens; 2001 Dec 04; 15(12):841-8. PubMed ID: 11773986
    [Abstract] [Full Text] [Related]

  • 20. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ, Ishola DA, Akintomide AO, Ajayi AA.
    J Hum Hypertens; 2003 Apr 04; 17(4):277-85. PubMed ID: 12714973
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.